SCHEMBL8636684

SCHEMBL8636684

CC(=O)N(c1ccccc1Cl)c1ccccc1C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.43
ALDH1A1 P00352 6/20 0.42
KMT2A Q03164 2/20 0.41
ATM Q13315 1/20 0.41
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 2/20 0.39
TSHR P16473 2/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
POLB P06746 2/20 0.38
CLCN2 P51788 1/20 0.38
PTPN1 P18031 1/20 0.37
TP53 P04637 1/20 0.37
GAA P10253 1/20 0.37
METAP2 P50579 1/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28600471 0.85 ALDH1A1 (0.53) KDM4EALDH1A1KMT2ACES2CES1
SCHEMBL8636888 0.81 NPSR1 (0.53) KDM4EALDH1A1KMT2AATMLMNA
SCHEMBL28600465 0.81 KMT2A (0.50) KDM4EALDH1A1KMT2AATMLMNA
SCHEMBL28618236 0.81 GAA (0.44) ALDH1A1CES2CES1MAPTTSHR
SCHEMBL28050368 0.80 NPC1 (0.45) KDM4EALDH1A1KMT2ALMNAMAPT
SCHEMBL9518578 0.76 NPSR1 (0.47) ALDH1A1KMT2AATMLMNATSHR
SCHEMBL27514150 0.75 GAA (0.53) KDM4EALDH1A1KMT2ALMNAMAPT
SCHEMBL6256662 0.75 CES2 (0.41) KDM4EALDH1A1KMT2AATMCES2
SCHEMBL9448424 0.74 ALDH1A1 (0.45) KDM4EALDH1A1KMT2ALMNAMAPT
Acetic Acid SCHEMBL29291113 0.73 ALDH1A1 (0.59) KDM4EALDH1A1KMT2AATMCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0855387-A1 2-ACYLAMINOBENZAMIDE DERIVATIVES AND PREVENTIVE AND REMEDY FOR DISEASES CAUSED BY THE SUPERMULTIPLICATION OF VASCULAR INTIMAL CELLS KISSEI PHARMACEUTICAL CO., LTD. (JP) 1998-07-29 EP disclosed